Search

  • Select Article Type
  • Abstract Supplements
  • Blood Group Review
  • Call to Arms
  • Hypothesis
  • In Memoriam
  • Interview
  • Introduction
  • Short Report
  • abstract
  • Abstracts
  • Article
  • book-review
  • case-report
  • case-study
  • Clinical Practice
  • Commentary
  • Conference Presentation
  • conference-report
  • congress-report
  • Correction
  • critical-appraisal
  • Editorial
  • Editorial Comment
  • Erratum
  • Events
  • Letter
  • Letter to Editor
  • mini-review
  • minireview
  • News
  • non-scientific
  • Obituary
  • original-paper
  • Original Research
  • Pictorial Review
  • Position Paper
  • Practice Report
  • Preface
  • Preliminary report
  • Product Review
  • rapid-communication
  • Report
  • research-article
  • Research Communicate
  • research-paper
  • Research Report
  • Review
  • review -article
  • review-article
  • review-paper
  • Review Paper
  • Sampling Methods
  • Scientific Commentary
  • short-communication
  • short-report
  • Student Essay
  • Varia
  • Welome
  • Select Journal
  • Immunohematology

 

Article | 30-November-2019

Inhibition of blood group antibodies by soluble substances

expression among individuals, such as anti-P1. Some antibodies can be inhibited by soluble substances such as sugars, proteins, and peptides; examples include ABH, Lewis, P1, Sda, Chido/Rodgers, and ID. Human saliva, hydatid cyst fluid, pigeon egg white, human or guinea pig urine, human serum, and human milk have been used as soluble substances to inhibit red blood cell (RBC) antibodies before the 1990s.1–4 Since then, recombinant blood group proteins (rBGPs) have also been shown to be effective in the

K.M. Byrne, C.M.C. Mercado, T.N. Nnabue, T.D. Paige, W.A. Flegel

Immunohematology, Volume 35 , ISSUE 1, 19–22

No Record Found..
Page Actions